ARTICLE | Clinical News
Hemispherx regulatory update
April 29, 1996 7:00 AM UTC
HEMXU received six European patents covering the company's nucleic acid technologies. The patents, covered under the number EPO 88307529.3, cover a broad set of closely related nucleic acid compounds ...